Mobile Version
Symbol |
Relationship |
Date |
Transaction |
Cost |
# Shares |
Value($) |
Total Shares |
Form 4 |
ANTH |
Chief Technology Officer |
Oct 12, 2015 |
Sale |
$6.15 |
1,205 |
7,411 |
7,896 |
Oct 13, 2015, 08:02 PM |
ANTH |
Chief Technology Officer |
Mar 25, 2014 |
Option Exercise |
$3.30 |
2,783 |
9,184 |
6,601 |
Mar 27, 2014, 09:57 PM |
ANTH |
Chief Technology Officer |
Jun 30, 2013 |
Option Exercise |
$0.49 |
2,248 |
1,102 |
75,074 |
Jul 02, 2013, 09:17 PM |
ANTH |
Chief Technology Officer |
Jan 03, 2013 |
Option Exercise |
$0.69 |
3,409 |
2,352 |
31,812 |
Jan 07, 2013, 09:18 PM |
ANTH |
Chief Technology Officer |
Jun 30, 2012 |
Option Exercise |
$0.69 |
1,838 |
1,268 |
24,821 |
Jul 03, 2012, 07:27 PM |
ANTH |
Chief Technology Officer |
Mar 01, 2012 |
Sale |
$6.57 |
2,000 |
13,140 |
26,659 |
Mar 05, 2012, 04:01 PM |
ANTH |
Chief Technology Officer |
Feb 01, 2012 |
Sale |
$7.67 |
2,000 |
15,340 |
21,241 |
Feb 03, 2012, 04:01 PM |
ANTH |
Chief Technology Officer |
Jan 10, 2012 |
Sale |
$6.51 |
800 |
5,205 |
23,241 |
Jan 12, 2012, 12:58 PM |
ANTH |
Chief Technology Officer |
Jan 06, 2012 |
Sale |
$6.50 |
1,200 |
7,800 |
24,441 |
Jan 10, 2012, 02:27 PM |
ANTH |
VP, Pharmaceutical R&D |
Jun 30, 2011 |
Option Exercise |
$8.17 |
3,670 |
29,984 |
25,641 |
Jul 05, 2011, 06:23 PM |
ANTH |
VP, Pharmaceutical R&D |
Apr 13, 2011 |
Option Exercise |
$1.51 |
3,311 |
5,000 |
29,311 |
Apr 14, 2011, 08:36 PM |
ANTH |
VP, Pharmaceutical R&D |
Sep 24, 2010 |
Buy |
$4.20 |
1,000 |
4,200 |
26,000 |
Sep 24, 2010, 09:22 PM |
Desktop Version
Symbol |
Relationship |
Date |
Transaction |
Value($) |
ANTH |
Chief Technology Officer |
Oct 12, 2015 |
Sale |
7,411 |
ANTH |
Chief Technology Officer |
Mar 25, 2014 |
Option Exercise |
9,184 |
ANTH |
Chief Technology Officer |
Jun 30, 2013 |
Option Exercise |
1,102 |
ANTH |
Chief Technology Officer |
Jan 03, 2013 |
Option Exercise |
2,352 |
ANTH |
Chief Technology Officer |
Jun 30, 2012 |
Option Exercise |
1,268 |
ANTH |
Chief Technology Officer |
Mar 01, 2012 |
Sale |
13,140 |
ANTH |
Chief Technology Officer |
Feb 01, 2012 |
Sale |
15,340 |
ANTH |
Chief Technology Officer |
Jan 10, 2012 |
Sale |
5,205 |
ANTH |
Chief Technology Officer |
Jan 06, 2012 |
Sale |
7,800 |
ANTH |
VP, Pharmaceutical R&D |
Jun 30, 2011 |
Option Exercise |
29,984 |
ANTH |
VP, Pharmaceutical R&D |
Apr 13, 2011 |
Option Exercise |
5,000 |
ANTH |
VP, Pharmaceutical R&D |
Sep 24, 2010 |
Buy |
4,200 |